Stay updated on L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial

Sign up to get notified when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the Latanoprost punctal plug delivery system is now displayed, with study details for a completed Phase 2 trial and no longer-recruiting status. It includes participant criteria, six study locations, the treatment plan, outcome measures, and record history.
    Difference
    34%
    Check dated 2026-11-11T17:43:57.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer version changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-28T15:47:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    An NIH announcement banner was added, notifying visitors about a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-21T20:44:44.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T20:39:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error instead of displaying the study record.
    Difference
    0.2%
    Check dated 2026-10-07T20:54:15.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the expected study record details, indicating an access restriction rather than a change to the study information.
    Difference
    15%
    Check dated 2026-09-23T22:03:36.000Z thumbnail image

Stay in the know with updates to L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial

Enter your email address, and we'll notify you when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.